• Investing Ideas
  • /
  • South Korean Pharmaceuticals & Biotech The Future Is Online
58 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A207940

Samsung BiologicsLtd
₩771,000.000.1%-3.3%₩54.9t₩1,034,260.87PE64xE15.8%n/a

A068270

Celltrion
₩189,000.007.0%16.0%₩39.2t₩230,117.65PE73.1xE40.3%0.3%

A196170

ALTEOGEN
₩177,200.002.0%286.5%₩9.4t₩168,333.33PS97.3xE124.4%n/a

A326030

SK Biopharmaceuticals
₩86,600.003.7%18.8%₩6.8t₩106,133.33PS19.1xE81.3%n/a

A000100

Yuhan
₩71,900.001.3%29.1%₩5.4t₩86,773.92PE39.5xE21.5%0.5%

A302440

SK bioscienceLtd
₩58,800.002.4%-29.2%₩4.5t₩58,000.00PE202.4xE-63.4%n/a

A128940

Hanmi Pharm
₩317,000.002.1%-1.9%₩4.0t₩408,985.96PE27.5xE12.2%0.2%

A068760

Celltrion Pharm
₩95,600.006.3%22.4%₩4.0tn/an/an/an/a

A000250

Sam Chun Dang Pharm
₩116,600.009.4%78.3%₩2.7tn/aPS13.8xn/a0%

A141080

LigaChem Biosciences
₩68,000.003.8%72.6%₩2.4t₩88,666.67PS71.6xE26.5%n/a

A008930

Hanmi Science
₩33,550.000.1%-22.1%₩2.3tn/aPE19.7xn/a0.6%

A145020

Hugel
₩201,000.00-3.4%79.1%₩2.2t₩218,777.78PE23.6xE18.6%n/a

A237690

ST PharmLtd
₩96,500.0012.6%5.1%₩1.8t₩105,555.56PE93.3xE37.2%0.5%

A009420

Hanall Biopharma
₩35,250.001.4%56.3%₩1.8t₩48,000.00PE509.3xE45.9%n/a

A214450

PharmaResearch
₩139,600.0017.5%38.4%₩1.4t₩175,000.00PE18.7xE20.5%0.7%

A185750

Chong Kun Dang Pharmaceutical
₩101,900.000.8%23.4%₩1.3t₩152,333.33PE6.1xE-23.6%1.0%

A006280

GC Biopharma
₩113,500.001.4%-10.2%₩1.3t₩144,666.67PB1xE82.3%1.3%

A069620

Daewoong Pharmaceutical
₩111,900.00-0.7%-1.8%₩1.3t₩160,333.33PE10.6xE1.3%0.5%

A298380

ABL Bio
₩25,500.002.8%14.6%₩1.2t₩36,666.67PS18.6xE-73.6%n/a

A039200

Oscotec
₩31,150.003.1%40.3%₩1.2t₩46,500.00PS240.3xS52.7%n/a

A140410

Mezzion PharmaLtd
₩38,350.00-0.5%47.2%₩1.1tn/aPS35.9xn/an/a

A214370

Caregen
₩22,200.003.7%-46.6%₩1.1tn/aPE27.3xn/a2.9%

A195940

HK inno.N
₩38,050.00-2.6%13.2%₩1.1t₩53,750.00n/aE23.6%0.9%

A096530

Seegene
₩22,350.002.1%-9.5%₩1.0t₩25,000.00PE1538.2xE108.1%3.6%
Page 1 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.